Catherine Novack

Stock Analyst at Jones Trading

(0)
# 4926
Out of 5,298 analysts
21
Total ratings
16.67%
Success rate
-34.02%
Average return
18 Stocks
Name Action Price Target Current % Upside Ratings Updated
PVLA Palvella Therapeutic...
Initiates Coverage On: Buy
45
23.75 89.47% 1 Mar 25, 2025
PRQR ProQR Therapeutics
Initiates Coverage On: Buy
11
1.18 832.2% 1 Feb 12, 2025
KRRO Korro Bio
Initiates Coverage On: Buy
130
14.3 809.09% 1 Nov 18, 2024
CAPR Capricor Therapeutic...
Initiates Coverage On: Buy
40
9.07 341.01% 1 Nov 18, 2024
EQ Equillium
Downgrades: Hold
n/a
n/a n/a 1 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 16
6.01 166.22% 2 Sep 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
1.96 614.29% 1 Sep 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 13
2.9 348.28% 2 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
1.69 373.37% 1 May 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.53 295.26% 1 Apr 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 10
1.19 740.34% 1 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
1.79 1129.05% 1 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
160
2.58 6101.55% 1 Jul 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
n/a n/a 1 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Dec 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
n/a n/a 1 Oct 4, 2021